CCR5 pathway candidate genes susceptible to HIV-infection.

被引:0
|
作者
Shrestha, S
Strathdee, SA
Galai, N
Thomas, D
Vlahov, D
O'Brien, SJ
Smith, MW
机构
[1] NCI, Basic Res Program, Frederick, MD 21701 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA
[4] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[5] NCI, Lab Genomic Divers, NIH, Frederick, MD 21701 USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
1259
引用
收藏
页码:385 / 385
页数:1
相关论文
共 50 条
  • [1] CCR5 and HIV infection
    Blanpain, C
    Libert, F
    Vassart, G
    Parmentier, M
    RECEPTORS & CHANNELS, 2002, 8 (01): : 19 - 31
  • [2] Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection
    Browning, J
    Horner, JW
    Pettoello-Mantovani, M
    Raker, C
    Yurasov, S
    DePinho, RA
    Goldstein, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14637 - 14641
  • [3] The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection
    Lehner, T
    TRENDS IN IMMUNOLOGY, 2002, 23 (07) : 347 - 351
  • [4] Treatment of HIV infection with the CCR5 antagonist maraviroc
    Kromdijk, Wiete
    Huitema, Alwin D. R.
    Mulder, Jan Willem
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1215 - 1223
  • [5] CCR5 and HIV infection, a view from Brussels
    Parmentier, Marc
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [6] Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population
    Pastinen, T
    Liitsola, K
    Niini, P
    Salminen, M
    Syvänen, AC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (08) : 695 - 698
  • [7] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
  • [8] Biology of CCR5 and its role in HIV infection and treatment
    Lederman, Michael M.
    Penn-Nicholson, Adam
    Cho, Michael
    Mosier, Donald
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07): : 815 - 826
  • [9] HIV-1 infection and CCR5Δ32 homozygosis
    Ballana, Ester
    Este, Jose A.
    FUTURE VIROLOGY, 2012, 7 (07) : 653 - 658
  • [10] Monoclonal CCR5 antibody for treatment of people with HIV infection
    Li, Lun
    Sun, TianTian
    Yang, KeHu
    Zhang, Peng
    Jia, Wen Qin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (12):